DIPYRIDAMOLE

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 523166
                    [Title] => Older age predicts early mortality after upper GI bleeding
                    [Summary] => 
Older age was the strongest predictor of early mortality in adults with gastrointestinal bleeding, after investigators controlled for medications and comorbidities, according to data from more than 1,000 adults treated at a single medical center.
                    [DatePublished] => 2009-11-15 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 8298
                    [Title] => Dipyridamole plus aspirin prevents recurrent stroke
                    [Summary] => 
            
                    [DatePublished] => 2007-07-26 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 225183
                    [Title] => Analysis shows safety of post-stroke therapy
                    [Summary] => Meta-analysis of nearly 340,000 post-stroke patients shows the superior safety of dipyridamole plus aspirin therapy.


The results of the analysis presented at the recent American Heart Association’s annual meeting, showed that the therapy was associated with the lowest bleeding risk compared with conventional dose and platelet therapies.


The meta-analysis included data from 50 clinical trials published from 1988 to 2002, with a total of 338,191 patients, to determine bleeding risks associated with antiplatelet agents.


                    [DatePublished] => 2003-10-23 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Older age predicts early mortality after upper GI bleeding

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | November 15, 2009 - 12:00am

Older age was the strongest predictor of early mortality in adults with gastrointestinal bleeding, after investigators controlled for medications and comorbidities, according to data from more than 1,000 adults treated...

Opinion

Dipyridamole plus aspirin prevents recurrent stroke

July 26, 2007 - 12:00am

Science and Environment

Analysis shows safety of post-stroke therapy

October 23, 2003 - 12:00am

Meta-analysis of nearly 340,000 post-stroke patients shows the superior safety of dipyridamole plus aspirin therapy. The results of the analysis presented at the recent American Heart Association’s annual meeting,...

Science and Environment